Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

Pediatric Infectious Disease Journal

Volumn 19, Issue 2, 2000, Pages 144-150

  Campagne, Géraed ^a   Garba, Amadou ^a   Fabre, Pascal ^b,e   Schuchat, Anne ^c,d   Ryall, Robert ^e   Boulanger, Denis ^a   Bybel, Mike ^e   Carlone, George ^d   Briantais, Philippe ^b   Ivanoff, Bernard ^c   Xerri, Bertrand ^b   Chippaux, Jean Philippe ^a  

^a Ctr Rech sur les Meningites les S   (Niger)

^b World Health Organisation ^*  (France)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e SANOFI PASTEUR   (France)

Author keywords

Conjugate; Meningococcal; Niger; Polysaccharide; Serogroup A; Serogroup C; Vaccine

Indexed keywords

DIPHTHERIA VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ARTICLE; BACTERICIDAL ACTIVITY; BLOOD SAMPLING; DRUG SAFETY; DRUG TOLERANCE; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; DIPHTHERIA TOXOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; NIGER; POLYSACCHARIDES, BACTERIAL; SEROTYPING; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0033966574     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200002000-00013     Document Type: Article

References (27)

1. Lapeyssonie L. La méningite cérébro-spinale en Afrique. Bull World Health Organ 1963;28(Suppl.):1-100.
2. Tikhomirov E, Santamaria M, Esteves K, Meningococcal disease: public health burden and control. World Health Stat Q 1997;50:170-7.
3. Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L, Chippaux JP. Epidemiology of bacterial meningitis in Niamey, Niger: 1981-1996. Bull World Health Organ 1999;77: 499-508.
4. Chippaux JP, Mounkaila A, Mounkeila N, Chaibou I, Djibo SL'épidémie de méningite cérébro-spinale du Niger de 1995. OCCGE Informations 1996;105:9-12.
5. Carlone GM, Frasch CE, Siber GR, et al. Multicenter comparison of levels of antibody to the N. meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol 1992;30: 154-9.
6. Gheesling LL, Carlone GM, Pais LB, et al. Multicenter comparison of N. meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 1994; 32:1475-82.
7. Maslanka SE, Gheesling LL, Libutti DE, et al. Standardization and a multilaboratory comparison of N. meningitidis serogroup A and C serum bactericidal assays: the Multilaboratory Study Group. Clin Diagn Lab Immunol 1997;4:156-67.
8. Lepow ML, Goldschneider I, Gold R, Randolph M, Gotschlich EC. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics 1977;60:673-80.
9. Amato Neto V, Finger H, Gotschlich EC, Feldman RA. Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children. Rev Inst Med Trop Sao Paulo 1974;16:149-53.
10. Twumasi PA Jr., Kumah S, Leach A, et al. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis 1995;171:632-8.
11. Leiberman JM, Chiu SS, Wong VK, et al. Safety and immunogenicity of a serogroups A/C N. meningitidis oligosaccharide-protein conjugate vaccine in young children: a randomized controlled trial. JAMA 1996;275:1499-503.
12. Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J Infect. Dis 1996;174:1360-3.
13. Sackett DL. Bias in analytic research. J Chron Dis 1979;32: 51-63.
14. Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129:1307-26.
15. Peltola H, Makela H, Kayhty H, et al. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 1977;297:686-91.
16. Kayhty H, Jousimies-Somer H, Peltola H, Maketa PH. Antibody response to capsular polysacharides of groups A and C N. meningitidis and H. influenzas type b during bacteremic disease. J Infect Dis 1981;143:32-41.
17. Goldschneider I, Lepow ML, Gotschlich EC, Mauck FT, Bachl F, Randolph M. Immunogenicity of group A and group C meningococcal polysaccharides in human infants. J Infect Dis 1973;128:769-76.
18. Frasch CE, Cartwright K, eds. Meningococcal disease. In: Meningococcal vaccines: past, present, and future. Chichester, UK: Wiley, 1995:245-83.
19. Maslanka SE, Tappero JW, Plikaytis BD, et al. Agedependent N. meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine. Infect Immun 1998;66:2453-9.
20. Schlesinger Y, Granoff DM, Avidity and bactericidal activity of antibody elicited by different H. influenzae type b conjugate vaccines: The Vaccine Study Group. JAMA 1992;267: 1489-94.
21. Granoff DM, Maslanka SE, Carlone GM, et al. A modified enzyme-linked immunosorbent assay for measurement antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol 1998;5:479-85.
22. Gold R, Lepow ML, Goldschneider I, Gotschlich EC. Immune response of human infants of polysaccharide vaccines of group A and C N. meningitidis. J Infect Dis 1977;136(Suppl):S31-5.
23. Gold R, Lepow ML, Goldschneider I, Draper TF, Gotschlich EC. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J Infect Dis 1979;140:690-7.
24. Leach A, Twumasi PA, Kumah S, et al. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis 1997;175:200-4.
25. MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM. Induction of immunologic memory by conjugated us. plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA 1998;280: 1685-9.
26. Granoff DM, Gupta RK, Belshe RB, Anderson EL. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis 1998;178:870-4.
27. Peltola H, Safary A, Kayhty HM, Karanko V, Andre FE. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics 1985;76: 91-6.